Flutoprazepam
- Level
- Commodity
- Parent
- 51401500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51401529This classification denotes an anticonvulsant agent with the molecular formula C19H16ClFN2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2GHY1101MM, chemically known as 7-chloro-1-(cyclopropylmethyl)-5-(o-fluorophenyl)-1,3-dihydro-2h-1,4-benzodiazepin-2-one but generally known as flutoprazepam, which bears US NIH Compound Identifier 3400. European Medicines Agency schedules Flutoprazepam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07764MIG. The term FLUTOPRAZEPAM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, No. 5 1981, List 21). FLUTOPRAZEPAM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule flutoprazepam under HS 29339940 and SITC 51577. As of Q4 2014, FLUTOPRAZEPAM remains the US FDA Preferred Term for this commodity. Flutoprazepam bears US NLM identifiers UMLS ID C0117998 and NCI Concept Code C65742. SMILES: CLC1CC2C(N(CC3CC3)C(=O)CN=C2C2C(F)CCCC2)CC1.
Same parent
Under 51401500 · 69Activities that produce or sell this
KBLI · 8Inherited from family 51400000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.